Dimention 14 said to be finalizing acquisition of NEOL Biosolutions, in bankruptcy proceedings since 2017
Dimention 14 ultima la adquisición de NEOL Biosolutions, en concurso de acreedores desde 2017
Intel ID : 269150
|
||||
| Intel ID | 269150 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Dimention 14
(31 Dec 2016) |
Revenue: EUR 0,02m Net Debt: EUR 0,47m |
||
| Date |
 |
||
| Country | |
||
| Region | |||
| Continent | |
||
| Geography |  |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services |
||
| Country |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.